Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Stopped early · Phase 1
Conditions studied: Melanoma (Skin)
In brief
RATIONALE: Riluzole may stop or slow the growth of tumor cells and may be an effective treatment for melanoma. PURPOSE: This early phase I trial is studying how well riluzole works in treating patients with stage III or stage IV melanoma that can be removed by surgery.
Key facts
- Study ID
- NCT00667901
- Run by
- University of Medicine and Dentistry of New Jersey
- People needed
- 15
- Starts
- 2007-02-01
- Expected to finish
- 2008-11-01
- Last updated by the study team
- 2009-12-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.